Rontis operates two manufacturing plants with state-of-the-art technologies in R&D, production & packaging of Interventional Cardiology & Radiology products, disposables for Nephrology and Liquid Administration.
Rontis operates since mid-2012 a brand new EU-GMP approved manufacturing plant, which is highly specialized in producing a great range of solid dose formulation forms. Rontis commitment on delivering the most innovative and specialty pharmaceutical products to its customers has been materialized in 2014 through the establishment of an in house state-of-the-art R&D lab focused on the developments of specialty pharmaceutical products.
Rontis operates one Dialysis Center, equipped with high-end dialysis machines (Fresenius Medical Care capital equipment) ensuring high quality services provided with responsibility and professionalism.
After extensive research and in collaboration with some of the most prominent researchers, Rontis developed a highly specialized range of Consumer Healthcare products. Rontis’ specialized range of dermaceutical and OTC products, Novalou, Novatopia and Nasalou address the special and over demanding skin care needs of Infants, Babies and Adults.
Additionally and in order to provide a newborn with the best possible nutritional values Rontis developed Rontamil Infant and Baby nutrition product range, the optimum choice when breastfeeding is not applied, with the most advanced blend of pre and pro-biotics (synbiotic).
Rontis Corporation’s Response to the Coronavirus
In the presence of this severe global health crisis and with the highest sense of responsibility towards society, its employees and global partners, Rontis Corporation is making a public commitment to contribute to the maximum extent in order to help combat the Coronavirus crisis…